Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1 | |
Ou, Yangyang; Zhai, Denggao; Wu, Nan; Li, Xiaoli* | |
刊名 | Gene
![]() |
2015 | |
卷号 | 572期号:1页码:116-122 |
关键词 | HCC hepatocellular carcinoma HepG2-R cisplatin-resistant HepG2 3′-UTR 3′-Untranslated Regions MiRNAs microRNAs FBS fetal bovine serum RT reverse transcription NCO oligonucleotide MTT (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide PI propidium iodide MiR-363 Mcl-1 HepG2-R Apoptosis Cisplatin |
ISSN号 | 0378-1119 |
DOI | 10.1016/j.gene.2015.07.002 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000361925900016 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3321126 |
专题 | 中南大学 |
作者单位 | 1.[Li, Xiaoli 2.Wu, Nan 3.Zhai, Denggao 4.Ou, Yangyang] Cent S Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China. |
推荐引用方式 GB/T 7714 | Ou, Yangyang,Zhai, Denggao,Wu, Nan,et al. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1[J]. Gene,2015,572(1):116-122. |
APA | Ou, Yangyang,Zhai, Denggao,Wu, Nan,&Li, Xiaoli*.(2015).Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.Gene,572(1),116-122. |
MLA | Ou, Yangyang,et al."Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1".Gene 572.1(2015):116-122. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论